Zhang Ming-Rong, Tsuchiyama Akio, Haradahira Terushi, Furutsuka Kenji, Yoshida Yuichiro, Kida Takayo, Noguchi Junko, Irie Toshiaki, Suzuki Kazutoshi
Department of Medical Imaging, National Institute of Radiological Sciences, Chiba, Japan.
Nucl Med Biol. 2002 May;29(4):463-8. doi: 10.1016/s0969-8051(01)00315-8.
N-[18F]Fluoroethyl-4-piperidyl acetate ([18F]FEtP4A), an analog of [11C]MP4A for mapping brain acetylcholineseterase (AchE) activity, was prepared by reacting 4-piperidyl acetate (P4A) with [18F]fluoroethyl bromide ([18F]FEtBr) using a newly developed automated system. Preliminary evaluation showed that the initial uptake of [18F]FEtP4A in the mouse brain was > 8% injected dose/g tissue. The distribution pattern of [18F]FEtP4A in the brain was striatum>cerebral cortex>cerebellum within 10-120 min post-injection, which reflected the distribution rank pattern of AchE activity in the brain. Moreover, chemical analysis of in vivo radioactive metabolites in the mouse brain indicated that 83% of [18F]FEtP4A was hydrolyzed to N-[18F]fluoroethyl-4-piperidinol ([18F]FEtP4OH) after 1 min intravenous injection. From these results, [18F]FEtP4A may become a promising PET tracer for mapping the AchE in vivo.